134 related articles for article (PubMed ID: 4660380)
1. [Principles of pharmacological immunosuppression in clinical application].
Gieldanowski J
Przegl Lek; 1972 Nov; 29(11):919-25. PubMed ID: 4660380
[No Abstract] [Full Text] [Related]
2. [Immunosuppressive therapy].
Schumacher K; Gross R
Internist (Berl); 1984 Jan; 25(1):51-9. PubMed ID: 6370894
[No Abstract] [Full Text] [Related]
3. [Immunologic and pharmacological principles for the use of immunosuppressive drugs in autoimmune diseases].
Floersheim GL
Schweiz Med Wochenschr; 1970 Dec; 100(52):2241-7. PubMed ID: 4946978
[No Abstract] [Full Text] [Related]
4. [What is certain in the treatment with immunosuppressive agents?].
Malchow H
Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
[No Abstract] [Full Text] [Related]
5. [Immunosuppression].
Amiel JL
Minerva Med; 1970 Jul; 61(55):3022-7. PubMed ID: 5427676
[No Abstract] [Full Text] [Related]
6. Perspectives of immunosuppression.
Balner H
Transplant Proc; 1971 Mar; 3(1):949-52. PubMed ID: 4941149
[No Abstract] [Full Text] [Related]
7. [Bases of immunosuppression and immunostimulation including their side effects in immunopathological diseases].
Deicher H
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():773-82. PubMed ID: 612054
[No Abstract] [Full Text] [Related]
8. [Immunosuppressive treatment and its side effects].
Scheiffarth F
Med Klin; 1971 Sep; 66(36):1183-9. PubMed ID: 4938064
[No Abstract] [Full Text] [Related]
9. [Round-table discussion on immunosuppressive agents in ophthalmology].
Arch Ophtalmol Rev Gen Ophtalmol; 1972 Jan; 32(1):75-100. PubMed ID: 4261214
[No Abstract] [Full Text] [Related]
10. [Significance of immunosuppression for the origin and growth of malignant tumors].
Reis HE
Dtsch Med Wochenschr; 1971 Jan; 96(4):170-4. PubMed ID: 4992740
[No Abstract] [Full Text] [Related]
11. [Practical use of immunosuppression].
Amiel JL
Munch Med Wochenschr; 1970 Mar; 112(12):497-500. PubMed ID: 4911634
[No Abstract] [Full Text] [Related]
12. Immunosuppression and neoplasia.
Balner H
Rev Eur Etud Clin Biol; 1970; 15(6):599-604. PubMed ID: 4919177
[No Abstract] [Full Text] [Related]
13. Immunosuppression by antilymphocyte serum and its effect on tumors indduced by 3-methylcholanthrene in mice.
Wagner JL; Haughton G
J Natl Cancer Inst; 1971 Jan; 46(1):1-10. PubMed ID: 5546191
[No Abstract] [Full Text] [Related]
14. Immunosuppressive therapy. Basic concepts and recent advances.
Lergier JE
Bol Asoc Med P R; 1972 Mar; 64(3):48-52. PubMed ID: 4591450
[No Abstract] [Full Text] [Related]
15. [Clinical significance of immunosuppression].
Heine KM
Dtsch Gesundheitsw; 1971 Nov; 26(46):2158-62. PubMed ID: 4948216
[No Abstract] [Full Text] [Related]
16. The clinical use of ALG.
Brendel W
Transplant Proc; 1971 Mar; 3(1):280-6. PubMed ID: 5095885
[No Abstract] [Full Text] [Related]
17. [Treatment of autoimmune diseases].
Wasastjerna C
Duodecim; 1973; 89(2):218-26. PubMed ID: 4685136
[No Abstract] [Full Text] [Related]
18. Minimizing the toxicity of antilymphocyte antibody therapy.
Pascual M; Rubin RH; Cosimi AB
Transplant Proc; 1996 Aug; 28(4):2113-4. PubMed ID: 8769171
[No Abstract] [Full Text] [Related]
19. Immunosuppression.
Parker CW; Vavra JD
Prog Hematol; 1969; 6():1-81. PubMed ID: 4181118
[No Abstract] [Full Text] [Related]
20. Suppression of the immune response.
Bradley J; Elson CJ
J Med Genet; 1971 Sep; 8(3):321-40. PubMed ID: 4106431
[No Abstract] [Full Text] [Related]
[Next] [New Search]
